Enovis Corporation

ENOV ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $1.94B $3.19B $3.43B $4.62B $4.21B $3.91B $693.4M $542.0M
Cost of Revenue $1.27B $2.19B $2.36B $3.15B $2.90B $2.76B $453.3M $350.6M
Gross Profit $671.6M $992.4M $1.07B $1.48B $1.31B $1.15B $240.1M $191.4M
Gross Margin 34.7% 31.2% 31.2% 32.0% 31.0% 29.4% 34.6% 35.3%
Operating Expenses
Research & Development — — — — — — $5.7M $6.2M
SG&A Expense $500.6M $696.8M $748.3M $1.01B $864.3M $908.4M $162.8M $133.5M
Operating Income $135.6M $236.8M $265.6M $409.6M $406.4M $140.0M $25.9M $34.4M
Operating Margin 7.0% 7.4% 7.7% 8.9% 9.7% 3.6% 3.7% 6.3%
Interest Expense $40.1M $30.3M $47.5M $51.3M $103.6M $91.6M $5.9M $6.7M
Pretax Income $48.6M $206.5M $218.1M $358.2M $302.8M $48.4M $20.0M $27.7M
Income Tax Expense $2.5M $51.8M $41.2M $-62.0M $93.7M $90.7M $15.4M $11.5M
Net Income $151.1M $128.1M $167.7M $392.1M $178.6M $-64.4M $4.6M $16.2M
Net Margin 7.8% 4.0% 4.9% 8.5% 4.2% -1.6% 0.7% 3.0%
EPS (Basic) $1.23 $1.04 $1.35 $3.06 $1.56 $-0.92 $0.05 $0.19
EPS (Diluted) $1.22 $1.04 $1.34 $3.02 $1.54 $-0.92 $0.05 $0.19
Shares Outstanding (Basic) 123.2M 122.9M 124.1M 121.1M 99.2M 91.1M 87.3M 86.8M
Shares Outstanding (Diluted) 124.0M 123.2M 124.9M 122.7M 100.4M 91.1M 88.5M 87.3M
Dividends Per Share — — — — — — — —
← Newer Page 2 of 3 Older →